Showing results (41-50 of 138) with videos related to
Sort By:
Pageof 14
Drug Metabolism and Pharmacokinetics|January 23, 2020
Cisplatin, rather than oxaliplatin, increases paracellular permeability of LLC-PK1 cells via activating protein kinase CYunpeng Zhang, Atsushi Yonezawa, Shunsaku Nakagawa, et al.Biological & Pharmaceutical Bulletin|March 1, 2022
Infliximab Treatment Persistence among Japanese Patients with Chronic Inflammatory Diseases: A Retrospective Japanese Claims Data StudySho Masui, Atsushi Yonezawa, Kenji Momo, et al.Pharmaceutical Research|April 20, 2005
Relationship between loperamide-induced sedative effect and digoxin pharmacokinetics in healthy Japanese subjectsMichiya Kobayashi, Hiroshi Saitoh, Michiko Yamaguchi, et al.Journal of Anesthesia|September 5, 2014
Target-controlled infusion and population pharmacokinetics of landiolol hydrochloride in gynecologic patientsTakayuki Kunisawa, Akio Yamagishi, Manabu Suno, et al.BMJ Open|February 16, 2021
Association of proton pump inhibitors and concomitant drugs with risk of acute kidney injury: a nested case-control studyKeiko Ikuta, Shunsaku Nakagawa, Kenji Momo, et al.Electrophoresis|November 20, 2012
Universal fluorescent labeling of amplification products using locked nucleic acidsMasaru Asari, Kumiko Oka, Tomohiro Omura, et al.European Journal of Clinical Pharmacology|October 18, 2014
Effect of CYP2C19 polymorphisms on the clinical outcome of low-dose clobazam therapy in Japanese patients with epilepsySachiyo Hashi, Ikuko Yano, Mai Shibata, et al.[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science|April 20, 2005
[Sex identification from DNA in old teeth]Masatugu Yoshida, Manabu Suno, Masaru Asari, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 21, 2009
[Survey of oxaliplatin-associated peripheral sensory neuropathy using an interview-based questionnaire in patients with advanced colorectal cancer]Machiko Satomi, Toru Kono, Noriaki Mamiya, et al.Cancer Diagnosis & Prognosis|May 6, 2024
Risk Factors for Adverse Events of Nanoliposomal Irinotecan Plus 5-Fluorouracil and L-leucovorinTakahiro Ito, Manabu Suno, Hideki Egawa, et al.Pageof 14